Motohiro Yukitake Selected Research

Motohiro Yukitake Research Topics

4	Multiple Sclerosis 05/2019 - 08/2003
3	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 04/2008 - 08/2003
2	Inflammation (Inflammations) 05/2022 - 08/2003
2	Cognitive Dysfunction 01/2022 - 01/2013
1	Coinfection 05/2022
1	Immune Reconstitution Inflammatory Syndrome 05/2022
1	Meningeal Tuberculosis (Tuberculous Meningitis) 05/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022
1	Erythema 01/2022
1	Neoplasms (Cancer) 01/2022
1	Hypokinesia (Bradykinesia) 01/2022
1	Mycosis Fungoides 01/2022
1	Ovarian Teratoma 01/2014
1	Teratoma (Teratoid Tumor) 01/2014
1	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 01/2014
1	Encephalitis (Encephalitis, Rasmussen) 01/2014
1	Unconsciousness (Loss of Consciousness) 10/2013
1	Neurologic Manifestations (Neurological Manifestations) 10/2013
1	Stroke (Strokes) 10/2013
1	Ischemic Stroke 10/2013
1	Cryptogenic Organizing Pneumonia 01/2013
1	Lymphoma (Lymphomas) 01/2013
1	Siderosis 01/2013
1	Progressive Multifocal Leukoencephalopathy 01/2013
1	Spinal Cord Diseases 04/2008
1	Atrophy 01/2008
1	Myasthenia Gravis 01/2008
1	Paraparesis 01/2008
1	Macrocytic Anemia 04/2007
1	Paraplegia (Spastic Paraplegia) 01/2006
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 02/2005
1	Torticollis (Wryneck) 01/2004
1	Polyradiculoneuropathy (Polyradiculoneuritis) 01/2004
1	Cerebellar Ataxia (Dysmetria) 12/2003
1	Myelitis 08/2003
1	Meningoencephalitis 08/2003
1	Leukocytosis (Pleocytosis) 08/2003
1	Cerebral Infarction 08/2003

4	AntibodiesIBA 01/2014 - 12/2004
2	SteroidsIBA 01/2022 - 01/2008
2	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 04/2008 - 12/2004
2	Immunoglobulin G (IgG)IBA 01/2008 - 08/2003
2	Proteins (Proteins, Gene)FDA Link 12/2004 - 08/2003
1	Pharmaceutical PreparationsIBA 05/2022
1	Brentuximab VedotinIBA 01/2022
1	Ficusin (Psoralen)IBA 01/2022
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2014
1	Tissue Plasminogen Activator (Alteplase)FDA Link 10/2013
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2013
1	Mefloquine (Lariam)FDA LinkGeneric 01/2013
1	Hemostatics (Antihemorrhagics)IBA 01/2013
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2008
1	Interferon-alpha (Interferon Alfa)IBA 01/2008
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 04/2007
1	SpastinIBA 01/2006
1	SS-A antibodiesIBA 02/2005
1	AutoantigensIBA 12/2004
1	Type A Botulinum Toxins (Botox)FDA Link 01/2004
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2004
1	Messenger RNA (mRNA)IBA 12/2003
1	PrionsIBA 08/2003
1	Phosphopyruvate Hydratase (Enolase)IBA 08/2003
1	14-3-3 Proteins (14-3-3 Protein)IBA 08/2003

6	Therapeutics 05/2022 - 01/2004
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2013
1	Hematopoietic Stem Cell Transplantation 01/2022
1	PUVA Therapy 01/2022
1	Activities of Daily Living (ADL) 01/2008
1	Injections 01/2004